EE9400040A - Composition for ophthalmic use - Google Patents
Composition for ophthalmic useInfo
- Publication number
- EE9400040A EE9400040A EE9400040A EE9400040A EE9400040A EE 9400040 A EE9400040 A EE 9400040A EE 9400040 A EE9400040 A EE 9400040A EE 9400040 A EE9400040 A EE 9400040A EE 9400040 A EE9400040 A EE 9400040A
- Authority
- EE
- Estonia
- Prior art keywords
- composition
- ophthalmic use
- ophthalmic
- Prior art date
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/40—Cyclodextrins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9302203A SE501482C2 (en) | 1993-06-24 | 1993-06-24 | Composition for topical administration of bispilocarpic acid diesters to the eye in the form of an aqueous solution |
Publications (1)
Publication Number | Publication Date |
---|---|
EE9400040A true EE9400040A (en) | 1995-12-15 |
Family
ID=20390417
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EE9400040A EE9400040A (en) | 1993-06-24 | 1994-08-18 | Composition for ophthalmic use |
Country Status (5)
Country | Link |
---|---|
AU (1) | AU6973194A (en) |
EE (1) | EE9400040A (en) |
LT (1) | LT3525B (en) |
SE (1) | SE501482C2 (en) |
WO (1) | WO1995000144A1 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2192965C (en) * | 1994-07-11 | 2007-12-04 | David W. Pate | Anandamide analogue compositions and method of treating intraocular hypertension using same |
GB9711643D0 (en) * | 1997-06-05 | 1997-07-30 | Janssen Pharmaceutica Nv | Glass thermoplastic systems |
US6933289B2 (en) | 2003-07-01 | 2005-08-23 | Allergan, Inc. | Inhibition of irritating side effects associated with use of a topical ophthalmic medication |
US7862552B2 (en) | 2005-05-09 | 2011-01-04 | Boston Scientific Scimed, Inc. | Medical devices for treating urological and uterine conditions |
WO2023225113A1 (en) * | 2022-05-18 | 2023-11-23 | Bexson Biomedical, Inc. | Complexing agent salt formulations of pharmaceutical compounds at low stoichiometric ratios |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS58126810A (en) * | 1981-12-24 | 1983-07-28 | Kaken Pharmaceut Co Ltd | Ophthalmic anti-inflammatory solution and preparation thereof |
TW200402B (en) * | 1990-08-13 | 1993-02-21 | Senju Pharma Co | |
FI98815C (en) * | 1990-11-30 | 1997-08-25 | Santen Oy | Process for the preparation of new pharmacologically useful ester derivatives of bispilocarpic acid |
-
1993
- 1993-06-24 SE SE9302203A patent/SE501482C2/en unknown
-
1994
- 1994-06-17 WO PCT/FI1994/000270 patent/WO1995000144A1/en active Application Filing
- 1994-06-17 AU AU69731/94A patent/AU6973194A/en not_active Abandoned
- 1994-06-23 LT LTIP1970A patent/LT3525B/en not_active IP Right Cessation
- 1994-08-18 EE EE9400040A patent/EE9400040A/en unknown
Also Published As
Publication number | Publication date |
---|---|
AU6973194A (en) | 1995-01-17 |
WO1995000144A1 (en) | 1995-01-05 |
LT3525B (en) | 1995-11-27 |
SE501482C2 (en) | 1995-02-27 |
LTIP1970A (en) | 1995-01-31 |
SE9302203L (en) | 1994-12-25 |
SE9302203D0 (en) | 1993-06-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9402379A (en) | Rubber composition | |
IL115479A0 (en) | Composition for ophthalmic use | |
FI941663A (en) | Tricritical point composition | |
DE69400062T2 (en) | Photopolymerizable composition | |
DE69416947T2 (en) | Rubber composition | |
DE59308042D1 (en) | Ophthalmic device | |
BR9407123A (en) | Herbicidal composition | |
DK0614607T3 (en) | Herbicide composition | |
EE9400040A (en) | Composition for ophthalmic use | |
DE69423504D1 (en) | PHOTOPOLYMERIZABLE COMPOSITION | |
EE9400039A (en) | Composition for ophthalmic use | |
KR950703340A (en) | Anti-RMS composition | |
DE9400967U1 (en) | glasses | |
DE9309509U1 (en) | glasses | |
DE9318184U1 (en) | glasses | |
ITMI920612A1 (en) | OPHTHALMIC COMPOSITION | |
ITMI911049A1 (en) | OPHTHALMIC COMPOSITION | |
BR9304388A (en) | Therapeutic composition for nasal use | |
KR940021122U (en) | Glasses | |
KR940027321U (en) | glasses | |
DE9315122U1 (en) | glasses | |
DE9312472U1 (en) | glasses | |
LTIP1969A (en) | Composition for ophthalmic use | |
DK40893D0 (en) | MICROBICID COMPOSITION | |
UA27833C2 (en) | WOOD-GLUE COMPOSITION |